Berger Financial Group, Inc

Position in GILD — Gilead Sciences, Inc.

CIK 1826136 Plymouth, MN

Position in GILD

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$5,820,736

-$750,002 QoQ

Shares Held

46,072

-2.3% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.87%

of 13F equity value

Holder Rank

#546

of 2,266 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Berger Financial Group, Inc holds $30,167,656 across 8 Drug Manufacturers - General names. GILD ranks #3 (19.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	39,841	$10,118,418
2	LLY	ELI LILLY & Co	6,514	$7,813,087
3	GILD	Gilead Sciences, Inc. This page	46,072	$5,820,736
4	ABBV	AbbVie Inc.	14,283	$3,594,174
5	AMGN	Amgen Inc	3,591	$1,300,372
6	MRK	Merck & Co., Inc.	8,364	$1,074,774
7	PFE	Pfizer Inc	9,471	$228,061
8	BMY	Bristol Myers Squibb Co	3,784	$218,034

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,820,736	46,072	-2.3%	Shares	Sole	2026-08-04
2026-03-31	$6,570,738	47,146	-22.9%	Shares	Sole	2026-04-28
2025-12-31	$7,507,023	61,162	-0.7%	Shares	Sole	2026-01-27
2025-09-30	$6,835,713	61,583	-0.2%	Shares	Sole	2025-10-14
2025-06-30	$6,840,789	61,701	+0.7%	Shares	Sole	2025-07-22
2025-03-31	$6,867,096	61,286	+2343.6%	Shares	Sole	2025-05-12
2023-03-31	$208,088	2,508	-96.5%	Shares	Sole	2023-04-24
2022-12-31	$6,200,859	72,229	+1.2%	Shares	Sole	2023-01-30
2022-09-30	$4,403,185	71,376	+3.2%	Shares	Sole	2022-10-27
2022-06-30	$4,274,223	69,151	+2.2%	Shares	Sole	2022-08-08
2022-03-31	$4,021,198	67,640	+16.7%	Shares	Sole	2022-05-10
2020-12-31	$3,375,700	57,942	—	Shares	Sole	2021-02-02
No filing history on record for this holder in this stock.